Last10K.com

Precision Biosciences Inc (DTIL) SEC Filing 8-K Material Event for the period ending Wednesday, October 2, 2019

Precision Biosciences Inc

HISTORY TOOLS
CIK: 1357874 Ticker: DTIL

View differences made from one to another to evaluate Precision Biosciences Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Precision Biosciences Inc.

Continue

Assess how Precision Biosciences Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Precision Biosciences Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Precision Biosciences Inc provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: DTIL
CIK: 1357874
Form Type: 8-K Corporate News
Accession Number: 0001564590-19-036138
Submitted to the SEC: Wed Oct 02 2019 7:31:01 AM EST
Accepted by the SEC: Wed Oct 02 2019
Period: Wednesday, October 2, 2019
Industry: Biological Products No Disgnostic Substances
Events:
  1. Financial Exhibit
  2. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/dtil/0001564590-19-036138.htm